MedPath

3D vs 2D HD Laparoscopy in Cholecystectomy

Not Applicable
Completed
Conditions
Cholecystolithiasis
Interventions
Procedure: 2D laparoscopic cholecystectomy
Procedure: 3D laparoscopic cholecystectomy
Registration Number
NCT02357589
Lead Sponsor
Helsinki University Central Hospital
Brief Summary

The 3D-systems have emerged also to the world of surgery, and the three-dimensional laparoscopic systems are gradually entering the operating rooms. In the normal laparoscopy there are only two-dimensional view, which is somewhat challenging when operating in three-dimensional environment. Even though the 3D-systems have been widely studied in laboratory circumstances, there are still no evidence of benefits of 3D vs 2D in clinical point of view and no prospective randomized trials have been published. Therefore, the purpose of this study is to investigate is there something to gain in changing into 3D laparoscopic system for cholecystectomy (LCC).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
210
Inclusion Criteria
  • Patients scheduled for laparoscopic cholecystectomy
Exclusion Criteria
  • Some other surgical operation planned during LCC
  • Expected major risk of conversion (e.g. multiple previous abdominal operation, previous peritonitis, previous cholecystitis)
  • Operating surgeon experience less than 5 3D laparoscopy operations

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
2D laparoscopic cholecystectomy2D laparoscopic cholecystectomyThe normal laparoscopic cholecystectomy with two dimensional view
3D laparoscopic cholecystectomy3D laparoscopic cholecystectomyThe normal laparoscopic cholecystectomy with three dimensional view
Primary Outcome Measures
NameTimeMethod
Duration of surgeryExpected average time of surgery 1 hour
Secondary Outcome Measures
NameTimeMethod
Intraoperative complicationsDuring the operation, expected average time of surgery 1 hour

Any complication during the operation e.g. hemorrhagic, liver, intestine or gallbladder rupture

Complications, Clavien-Dindo classification30 days after randomization
Postoperative stay in hospitalExpected range 0-7 day
BleedingDuring the operation, expected average time of surgery 1 hour
Mortality30 days after randomization
Need for conversion into open surgeryDuring the operation, expected average time of surgery 1 hour
Total need of opioids in milligramsExpected range 0-7 day
Operation theatre timeExpected average 1,5 hours
Number of participants with readmission(s)30 days after randomization
Postoperative pain, VASExpected range 0-7 day

Trial Locations

Locations (1)

Helsinki University Central Hospital

🇫🇮

Helsinki, Finland

© Copyright 2025. All Rights Reserved by MedPath